These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002 [TBL] [Abstract][Full Text] [Related]
3. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study. Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762 [TBL] [Abstract][Full Text] [Related]
4. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles. Yu CX; Tan JW; Rullah K; Imran S; Tham CL J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457 [TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19. Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765 [TBL] [Abstract][Full Text] [Related]
6. Targeting SARS-CoV-2 non-structural protein 13 via helicase-inhibitor-repurposing and non-structural protein 16 through pharmacophore-based screening. Samdani MN; Morshed N; Reza R; Asaduzzaman M; Islam ABMMK Mol Divers; 2023 Jun; 27(3):1067-1085. PubMed ID: 35690957 [TBL] [Abstract][Full Text] [Related]
7. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis. Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953 [TBL] [Abstract][Full Text] [Related]
8. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach. Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432 [TBL] [Abstract][Full Text] [Related]
9. Scaffold identification and drug repurposing for finding potential Dengue envelope inhibitors through ligand-based pharmacophore model. Priya S; Alli VJ; Jadav SS J Biomol Struct Dyn; 2023; 41(21):11916-11929. PubMed ID: 36709443 [TBL] [Abstract][Full Text] [Related]
10. Plant derived active compounds as potential anti SARS-CoV-2 agents: an Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565 [TBL] [Abstract][Full Text] [Related]
11. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2. Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738 [TBL] [Abstract][Full Text] [Related]
13. Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach. Akash S; Hossain A; Hossain MS; Rahman MM; Ahmed MZ; Ali N; Valis M; Kuca K; Sharma R Front Cell Infect Microbiol; 2023; 13():1157627. PubMed ID: 37033493 [TBL] [Abstract][Full Text] [Related]
14. Search for potentially biased epidermal growth factor receptor (EGFR) inhibitors through pharmacophore modelling, molecular docking, and molecular dynamics (MD) simulation approaches. Jethwa M; Gangopadhyay A; Saha A J Biomol Struct Dyn; 2023 Mar; 41(5):1681-1689. PubMed ID: 35014597 [TBL] [Abstract][Full Text] [Related]
15. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus. Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340 [TBL] [Abstract][Full Text] [Related]